In the News

2024

February 14, 2023
Neurona Therapeutics Raises $120M Financing, Cell Therapy Shows Positive Outcomes in CIRM-Funded Trial

February 8, 2023
Neurona raises $120M to take epilepsy cell therapy to late-stage development

February 8, 2024
Don't call it a comeback, but Neurona knocks out $120M raise a year after layoffs

January 25, 2024
Duke Comprehensive Epilepsy Center Conducting First-In-Human Studies of Cell Transplantation for Epilepsy

January 15, 2024
Neurona's Interneuron Cell Therapy Looks Promising in Drug-Resistant Mesial Temporal Lobe Epilepsy

2023

Click to play video of Interview with patient caregiver

Interview with patient caregiver at the XVII Conference on Epilepsy Therapies & Diagnostics Development (ETDD)
(with permission from ETDD, patient and caregiver)

December 14, 2023
Regenerative Brain Cell Therapy: One Woman’s Journey to Seizure Freedom

November 29, 2023
Ep. 253: “Heart Failure Genes” Featuring Dr. Roger Foo

November 27, 2023
NRTX-1001 Shows Seizure Suppression in Preclinical Drug-Resistant Focal Epilepsy Models

October 30, 2023
Groundbreaking Clinical Trial at Upstate Offers Hope for Epilepsy Patients

October 6, 2023
Regenerative Cell Therapy for Epilepsy

October 5, 2023
Cell Therapy for Drug-Resistant Epilepsy a Preclinical Success

September 25, 2023
Doctors test experimental treatment to combat seizures in epilepsy patients

September 2023
Promising Initial Clinical Data for Drug-Resistant Epilepsy

August 9, 2023
After 25 Years of Hype, Embryonic Stem Cells are Still Waiting for Their Moment

July 26, 2023
UC San Diego Health among First in Nation to Perform Regenerative Brain Cell Procedure for Epilepsy

June 25, 2023
One Shot Epilepsy Treatment Reduced Seizures by 95% in First Two Patients

June 20, 2023
Inhibitory Interneuron Cell Therapy Reduces Seizures in First 2 Patients with MTLE

June 18, 2023
Two Epilepsy Patients’ Seizures Greatly Reduced in Stem Cell Therapy Trial

June 2, 2023
OHSU Epilepsy Patient Nearly Seizure-Free After Regenerative Brain Cell Therapy Procedure

May 18, 2023
OHSU Patient Nearly Seizure-Free After Regenerative Brain Cell Therapy

May 18, 2023
Treatment Shows Promise in Reducing Seizures

April 25, 2023
Cell Therapy NRTX-1001 Posts Positive Preliminary Data in Drug-Resistant Mesial Temporal Lobe Epilepsy

April 22, 2023
2023 AAN Annual Meeting Top Science Press Conference – American Academy of Neurology
Interview with Dr. David Spencer at 36:45 – 54:00

April 21, 2023
Exciting Early Results With Novel Cell Therapy for Focal Epilepsy

April 21, 2023
Novel Neural Cell Therapy a Cure for Focal Epilepsy?

February 17, 2023
The New Era of Life Sciences 2023

January 30, 2023
Webinar: Stem Cells & Epilepsy: A New Therapeutic Approach for Treating Drug-Resistant Epilepsy

January 19, 2023
The News That Mattered in 2022: Neurology Today Editorial Board Top Picks

2022

December 22, 2022
Cell Therapy NRTX-1001 Shows Significant Effect on Drug-Resistant Epilepsy in Early Data

December 5, 2022
Neural Cell Therapy Reduce Seizures in MTLE

November 28, 2022
Neurona Therapeutics Update: First two patients who received treatment experienced significantly less seizures

November 17, 2022
Episode 496: Episode 22-47 Ideas, Ideas, Ideas

November 2, 2022
OHSU Second in the Country to Perform Regenerative Brain Cell Therapy Procedure

July 1, 2022
First Patient Dosed in Clinical Trial for a Drug-Resistant Form of Epilepsy

June 30, 2022
Neurona Therapeutics Dosed Initial Subject in First Clinical Trial of Regenerative Human Cell Therapy

June 29, 2022
Upstate doses first patient in national clinical trial of regenerative human cell therapy for treatment of epilepsy

June 1, 2022
The Long Road to Developing a Therapy for Epilepsy

February 24, 2022
Exploring Cell Therapy for the Treatment of Drug-Resistant Epilepsy

2021

November 9, 2021
Promising new approach for people with epilepsy

November 9, 2021
Focal Epilepsy Cell Therapy NRTX-1001 Gets IND Clearance, Set to Begin Phase 1/2 Trial

September 24, 2021
A Mind For Medicine. Researchers are tapping into the regenerative power of stem cells to treat central nervous system disorders.

June 23, 2021
Neurona Therapeutics is dashing to the clinic with its cell therapy for epilepsy — but first, another venture round

May 19, 2021
Transplanting Specialized Neurons Cory R Nicholas, PhD, Co-Founder and CEO of Neurona Therapeutics, talks to Pharmafile about the world of neurological disorders and transplantation. (This article is taken from Pharmafile Spring 2021, pages 54-55. © Samedan Ltd)

2016-2009

September 22, 2016
Human Neuron Transplants Treat Spinal Cord Injury in Mice

May 4, 2015
The Daily Startup: How This VC Firm is Building Its Own Biotech Companies

December 24, 2014
Stem cells to transplant in the brain: Stealth UCSF spinout Neurona Therapeutics raises $7.6M

May 07, 2013
Successful transplantation of lab-derived interneurons in mice

May 07, 2013
Epileptic mice cured with transplantation of MGE interneurons

June 21, 2012
Reining in pain

September 10, 2009
Progenitor cell therapy for epilepsy


NRTX-1001 is an investigational candidate and is being evaluated in ongoing clinical trials. NRTX-1001 has not been approved by any regulatory authority for commercial use or deemed to be safe or effective for any indication.